Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

HIV-1 copathogens are believed to play a critical role in progression to AIDS. Human cytomegalovirus (HCMV) has a high prevalence in the general population and is a common copathogen in HIV-1-infected individuals. Important events in copathogen interactions with HIV-1 take place in lymphoid tissue where critical events in HIV-1 disease occur. Here, we used an experimental system of human lymphoid tissue ex vivo to investigate interactions of HCMV with HIV-1. We inoculated ex vivo blocks of human lymphoid tissue with a recombinant strain of HCMV, expressing the green fluorescent protein, and HIV-1 and monitored viral replication and the phenotype of productively infected cells. HCMV readily replicated in tissue blocks as revealed by the release of HCMV viral DNA and an increasing number of viral-positive cells. Immunophenotyping of HCMV-infected cells showed a preferential infection of activated lymphocytes. The number of these cells significantly increased in HIV-1-coinfected tissues. Accordingly, HCMV replication was enhanced 2- to-3 fold. This upregulation occurred in tissues infected with either CXCR4- or CCR5-utilizing HIV-1. Thus, HIV-1 creates new targets for HCMV, which may explain the strong association of HCMV with HIV-1 infection in vivo. Ex vivo-infected human lymphoid tissue constitutes a model to study the mechanisms of HCMV tissue pathogenesis and its interactions with HIV-1 and this model may provide new targets for anti-HIV-1 therapy.

[1]  J. Grivel,et al.  Use of human tissue explants to study human infectious agents , 2009, Nature Protocols.

[2]  L. Margolis,et al.  Coinfecting viruses as determinants of HIV disease , 2009, Current HIV/AIDS reports.

[3]  M. Lederman,et al.  The lymph node in HIV pathogenesis. , 2008, Seminars in immunology.

[4]  J. Grivel,et al.  HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. , 2008, Blood.

[5]  J. Grivel,et al.  Viral Interactions in Human Lymphoid Tissue: Human Herpesvirus 7 Suppresses the Replication of CCR5-Tropic Human Immunodeficiency Virus Type 1 via CD4 Modulation , 2006, Journal of Virology.

[6]  J. Sinclair,et al.  Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection. , 2006, The Journal of general virology.

[7]  J. Stapleton,et al.  HIV and GB virus C coinfection. , 2006, The Lancet. Infectious diseases.

[8]  K. Mayer,et al.  Human immunodeficiency virus type-1 episomal cDNA in semen , 2005, AIDS research and therapy.

[9]  W. Moss,et al.  Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. , 2005, The Journal of infectious diseases.

[10]  G. Pantaleo,et al.  Functional Heterogeneity of Memory CD4 T Cell Responses in Different Conditions of Antigen Exposure and Persistence1 , 2005, The Journal of Immunology.

[11]  Jiahong Xu,et al.  HIV type 1 and cytomegalovirus coinfection in the female genital tract. , 2004, The Journal of infectious diseases.

[12]  Michael Boeckh,et al.  The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. , 2004, Blood.

[13]  Y. Shimabukuro,et al.  Induction of CD13 on T-lymphocytes by Adhesive Interaction with Gingival Fibroblasts , 2003, Journal of dental research.

[14]  J. Grivel,et al.  Pathogenic Effects of Human Herpesvirus 6 in Human Lymphoid Tissue Ex Vivo , 2003, Journal of Virology.

[15]  S. Huong,et al.  Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus , 2003, Nature.

[16]  P. Kantipong,et al.  Decrease in human immunodeficiency virus type 1 load during acute dengue fever. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Wünschmann,et al.  Interactions between GB virus type C and HIV , 2002, Current infectious disease reports.

[18]  E. Mocarski,et al.  Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. , 2002, Blood.

[19]  T. Quinn,et al.  Suppression of human immunodeficiency virus replication during acute measles. , 2002, The Journal of infectious diseases.

[20]  R. Sudlow,et al.  Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. , 2001, The Journal of infectious diseases.

[21]  A. Fauci,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes Are Similar to HIV-1 Subtype B in that Coreceptor Specificity Is a Determinant of Cytopathicity in Human Lymphoid Tissue Infected Ex Vivo , 2001, Journal of Virology.

[22]  W. Fitzgerald,et al.  Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 , 2001, Nature Medicine.

[23]  R. Al-Attiyah,et al.  The use of flow cytometry for the detection of CMV‐specific antigen (pp65) in leukocytes of kidney recipients , 2000, Clinical transplantation.

[24]  D. Geraghty,et al.  Human Cytomegalovirus Gene Products US3 and US6 Down-Regulate Trophoblast Class I MHC Molecules1 , 2000, The Journal of Immunology.

[25]  Diana D. Huang,et al.  Human Cytomegalovirus UL144 Open Reading Frame: Sequence Hypervariability in Low-Passage Clinical Isolates , 1999, Journal of Virology.

[26]  J. Zeh,et al.  Risk factors for HIV-1 shedding in semen. , 1999, American journal of epidemiology.

[27]  E. Mocarski,et al.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Huemer,et al.  Influence of viral infection on expression of cell surface antigens in human retinal pigment epithelial cells , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  J. Zimmerberg,et al.  Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. , 1997, AIDS research and human retroviruses.

[30]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Zimmerberg,et al.  Infection of human tonsil histocultures: A model for HIV pathogenesis , 1995, Nature Medicine.

[32]  F. Monpoux,et al.  La transmission maternofœtale du VIH , 1995 .

[33]  J. Langner,et al.  Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma , 1994, Immunology Letters.

[34]  J. Wahlberg,et al.  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection , 1993, Journal of virology.

[35]  S. Larsson,et al.  Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. , 1993, Transplantation proceedings.

[36]  J. Langner,et al.  Demonstration of CD13/Aminopeptidase N on Synovial Fluid T Cells from Patients with Different Forms of Joint Effusions , 1993, Immunobiology.

[37]  S. S. St. Jeor,et al.  Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus , 1979, Infection and immunity.

[38]  Anthony Sheung,et al.  Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. , 2006, The Journal of infectious diseases.

[39]  J. Siennicka.  Detection of CMV infected cells by flow cytometry--evaluation of MAbs CCH2 and AAC10 directed against early and late CMV antigens. , 2004, Polish journal of microbiology.

[40]  R. Jaffe,et al.  Early detection of cytomegalovirus in the allograft liver biopsy: a comparison of methods. , 1987, Pediatric pathology.